An International Publisher for Academic and Scientific Journals
Author Login 
SAS Journal of Medicine | Volume-8 | Issue-08
Using Ultrasound in the Confirmation of Polycystic Ovary Syndrome
Diana Sulieman Aljammal, Shefaa Saleh Almashaqbeh, Hend Moqbel Harahsheh, Rana Ahmed Alkrimeen, Rawan Nahed Hiyari
Published: Aug. 9, 2022 | 160 120
DOI: 10.36347/sasjm.2022.v08i08.003
Pages: 528-532
Downloads
Abstract
Background: Polycystic ovary syndrome (PCOS) is found in 6–15% of females of reproductive age (1, 2) with polycystic ovaries on pelvic ultrasonography. Polycystic ovaries are nonspecific on ultrasound, overlapping with findings in 40% of people who do not have the syndrome. Aim: To assess the advantages of transabdominal pelvic ultrasound in the confirmation of PCOS. Methods: This prospective investigation compared 45 female participants with PCOS, average age 14.9 years (group I) with 82 female participants with acute appendicitis, average age 14.3 years (group II), at Hashim Bin Al-hussein Military Hospital, Zarqa, Jordan, during the period 2018-2020. Transabdominal pelvic ultrasound was assessed in the two groups. Ovarian volume (0.5 x length x width x thickness) and follicle (3–10 mm in a single plane (follicle number per section) for each ovary) were followed up. The modified Rotterdam criteria (volume more than 10 ml +/- number of follicles more than 10) for polycystic ovaries were used. Pelvic transabdominal ultrasound was performed in cases of doubtful appendicitis with longitudinal and transverse images of the two ovaries and uterus (and endometrial stripe). Correlation between continuous variables was conducted using nonparametric Wilcoxon tests and correlation between categorical variables was performed using Fisher’s exact test. A P-value of less than 0.05 was considered statistically significant. Results: The modified Rotterdam criteria for polycystic ovary morphology (PCOM) were recorded more commonly in group I (66.7% [30/45]) than in group II (10.97% [9/82]). In group I, 30 participants were positive for PCOM: 12/30 (40%) by number of follicles more than 10, 4/30 (13.3%) by volume and 14/30 (46.7%) by number and volume. Most ultrasounds were accurate for confirmation (group I = 93.3% [42/45] and group II = 91.5% [75/82]). In group II, nine participants were positive for PCOM: three by follicle criteria, two by volume and four by volume and ..........